These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24615324)

  • 1. HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy.
    Untiet S; Vassilakos P; McCarey C; Tebeu PM; Kengne-Fosso G; Menoud PA; Boulvain M; Navarria I; Petignat P
    Int J Cancer; 2014 Oct; 135(8):1911-7. PubMed ID: 24615324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test.
    Lorenzi AT; Fregnani JH; Possati-Resende JC; Neto CS; Villa LL; Longatto-Filho A
    Gynecol Oncol; 2013 Oct; 131(1):131-4. PubMed ID: 23880151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus self-sampling in Cameroon: women's uncertainties over the reliability of the method are barriers to acceptance.
    Berner A; Hassel SB; Tebeu PM; Untiet S; Kengne-Fosso G; Navarria I; Boulvain M; Vassilakos P; Petignat P
    J Low Genit Tract Dis; 2013 Jul; 17(3):235-41. PubMed ID: 23422643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
    Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
    Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing the 3T-approach for cervical cancer screening in Cameroon: Preliminary results on program performance.
    Levy J; de Preux M; Kenfack B; Sormani J; Catarino R; Tincho EF; Frund C; Fouogue JT; Vassilakos P; Petignat P
    Cancer Med; 2020 Oct; 9(19):7293-7300. PubMed ID: 32757469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa.
    Fokom Domgue J; Futuh B; Ngalla C; Kakute P; Manjuh F; Manga S; Nulah K; Welty E; Schmeler K; Welty T
    Int J Cancer; 2020 Jul; 147(1):128-138. PubMed ID: 31633801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.
    Kunckler M; Schumacher F; Kenfack B; Catarino R; Viviano M; Tincho E; Tebeu PM; Temogne L; Vassilakos P; Petignat P
    Cancer Med; 2017 Jul; 6(7):1752-1761. PubMed ID: 28580596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.
    McKenna M; McMenamin MM
    Cancer Cytopathol; 2014 Sep; 122(9):702-10. PubMed ID: 24888573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
    Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
    BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa.
    Mitchell SM; Sekikubo M; Biryabarema C; Byamugisha JJ; Steinberg M; Jeronimo J; Money DM; Christilaw J; Ogilvie GS
    Am J Obstet Gynecol; 2014 Jan; 210(1):81.e1-7. PubMed ID: 23999419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
    Pimple S; Shastri SS
    Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.